YAP1 and pancreatic adenocarcinoma: Further Mutual Exclusivity analysis demonstrates a tendency towards co-occurrence between the PRKCI and YAP1 mRNA alterations (p < 0.001) in pancreatic adenocarcinoma (Figure 6C), adding an extra line of evidence to the correlation between PKCι and YAP1 expression alterations, and the activation of PKCι-YAP1 signaling in Kras mutant PDAC.